Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

148
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
148
Hybridoma Technology01:31

Hybridoma Technology

13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
Synthetic Biology02:55

Synthetic Biology

4.4K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
4.4K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

160
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hsa_circ_0000520 Promotes Invasion and Metastasis of Breast Cancer Cells by Targeting HSP90AA1.

Breast cancer (Dove Medical Press)·2026
Same author

Exploring specialized metabolic pathways in medicinal plants with single-cell and spatial omics.

Acta pharmaceutica Sinica. B·2026
Same author

Bridging data and discovery: a survey on knowledge graphs in AI for science.

National science review·2026
Same author

Integrated UPLC-QTOF-MS and Network Pharmacology for Predicting Active Constituents and Pharmacological Mechanisms of Yinxingye Tablets Against Oxidative Stress.

Biomedical chromatography : BMC·2026
Same author

Metabolomics Integrated with Mass Spectrometry Imaging Reveals Novel Action of Rb1 in Ischemic Stroke.

Journal of proteome research·2026
Same author

Rare taxa enhance microbial network complexity and drive nitrification and denitrification processes in river ecosystems.

Environmental microbiome·2026

Related Experiment Video

Updated: Apr 23, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.6K

Harnessing biosynthetic logic for next-generation ADC payloads.

Miaomiao Cai1,2, Xinyuan Pan1, Wei Shen1

  • 1School of Pharmacy, Zhejiang University, Hangzhou 310058, China. guangleima@zju.edu.cn.

Chemical Society Reviews
|April 22, 2026
PubMed
Summary

Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment. Advances in biosynthesis and synthetic biology are expanding payload diversity for more effective and safer cancer therapies.

More Related Videos

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.0K
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

20.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.6K
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.0K
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
09:06

Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition

Published on: December 23, 2016

20.8K

Area of Science:

  • Oncology
  • Biochemistry
  • Synthetic Biology

Background:

  • Antibody-drug conjugates (ADCs) combine targeted antibody delivery with potent small-molecule payloads for cancer therapy.
  • Current ADC payloads are limited to natural products, restricting mechanistic diversity and potentially causing resistance.
  • Limited payload variety hinders broader tumor coverage and therapeutic optimization.

Purpose of the Study:

  • To review recent advances in the discovery, biosynthesis, and manufacturing of ADC payloads.
  • To explore how genome mining and synthetic biology can expand payload chemical space.
  • To discuss emerging non-toxin payloads and their potential in ADC development.

Main Methods:

  • Summarizing recent literature on ADC payload discovery and biosynthesis.
  • Analyzing the role of biosynthetic gene clusters and enzymatic logic.
  • Examining strategies for scalable payload production.

Main Results:

  • Breakthroughs in genome mining and synthetic biology are enabling the understanding and engineering of payload biosynthesis.
  • Knowledge of biosynthetic pathways offers new routes to diverse and novel ADC payloads.
  • Emerging non-toxin modalities present alternatives or complements to cytotoxic payloads.

Conclusions:

  • Harnessing biosynthetic knowledge is key to diversifying ADC payloads.
  • Expanding payload chemical space can lead to safer, more effective, and mechanistically sophisticated cancer therapies.
  • Future ADC development can benefit from a broader range of payloads, including non-toxin options.